Cargando…

Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature

Radiation necrosis (RN) of brain tissue is a serious late complication of brain irradiation and recently bevacizumab has been suggested as treatment option of RN. There is a lack of data in the literature regarding the effectiveness of bevacizumab for the treatment of RN. The purpose of this review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delishaj, Durim, Ursino, Stefano, Pasqualetti, Francesco, Cristaudo, Agostino, Cosottini, Mirco, Fabrini, Maria Grazia, Paiar, Fabiola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330769/ https://www.ncbi.nlm.nih.gov/pubmed/28270886 http://dx.doi.org/10.14740/jocmr2936e

Ejemplares similares

The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis
por: Delishaj, Durim, et al.
Publicado: (2015)

Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol
por: Delishaj, Durim, et al.
Publicado: (2018)

Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature
por: Delishaj, Durim, et al.
Publicado: (2016)

Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series
por: Delishaj, Durim, et al.
Publicado: (2015)

Squamous cell carcinoma (SCC) of the Pyriform sinus with multiple metachronous brain metastases, a case report
por: Cristaudo, Agostino, et al.
Publicado: (2020)

Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?
por: Laliscia, Concetta, et al.
Publicado: (2016)

Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results
por: Delishaj, Durim, et al.
Publicado: (2018)

Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
por: Delishaj, Durim, et al.
Publicado: (2021)

Integrating stereotactic radiotherapy and systemic therapies
por: Palumbo, Isabella, et al.
Publicado: (2022)

Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients
por: Wang, Yang, et al.
Publicado: (2012)

Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab
por: Voss, Martin, et al.
Publicado: (2019)

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
por: Soffietti, Riccardo, et al.
Publicado: (2013)

Changes in Protein Level in the Cerebrospinal Fluid of a Patient with Cerebral Radiation Necrosis Treated with Bevacizumab
por: Yano, Hirohito, et al.
Publicado: (2014)

A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis
por: Alessandretti, Matheus, et al.
Publicado: (2013)

Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review
por: Liao, Guixiang, et al.
Publicado: (2021)

Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience
por: Lee, Shin Heon, et al.
Publicado: (2023)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis
por: Park, Moowan, et al.
Publicado: (2020)

Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022)

Vismodegibfor the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study
por: Laliscia, Concetta, et al.
Publicado: (2019)

Single-shot bevacizumab for cerebral radiation injury
por: Voss, Martin, et al.
Publicado: (2021)

Resolution of Radiation-Induced Necrosis in Arteriovenous Malformation with Bevacizumab: A Case Report and Review of Current Literature
por: Kwong, Forrest, et al.
Publicado: (2021)

Addendum: Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022)

Incorporating dose–volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy
por: Ursino, Stefano, et al.
Publicado: (2020)

New insights on clinical perspectives of FLASH radiotherapy: from low- to very high electron energy
por: Ursino, Stefano, et al.
Publicado: (2023)

Bipolar Disorder Treatments and Ovarian Cancer: A Systematic Review
por: Miniati, Mario, et al.
Publicado: (2020)

Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
por: Zhuang, Hongqing, et al.
Publicado: (2016)

High-dose bevacizumab for radiation-induced brain necrosis: a case report
por: Panagiotou, Emmanouil, et al.
Publicado: (2023)

Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis
por: Khan, Muhammad, et al.
Publicado: (2021)

Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase‐positive lung cancer
por: Tanigawa, Kengo, et al.
Publicado: (2019)

High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses – 14 years of single-centre experience
por: Soatti, Carlo Pietro, et al.
Publicado: (2020)

Management of grade 3 acute dermatitis with moist desquamation after adjuvant chest wall radiotherapy: a case report
por: Delishaj, Durim, et al.
Publicado: (2020)

Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?
por: Pasqualetti, Francesco, et al.
Publicado: (2023)

MLTI-06. BEVACIZUMAB VERSUS SURGICAL INTERVENTION FOR RADIATION NECROSIS IN PREVIOUSLY IRRADIATED BRAIN METASTASES
por: Hong, Christopher, et al.
Publicado: (2019)

Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases
por: Weng, Yuxiang, et al.
Publicado: (2021)

BEVACIZUMAB FOR SYMPTOMATIC RADIATION NECROSIS IN BRAIN METASTASES: OUTCOMES FROM A SINGLE-CENTER RETROSPECTIVE ANALYSIS
por: Roberto, Katrina, et al.
Publicado: (2023)

Delayed Cerebral Radiation Necrosis after Neutron Beam Radiation of a Parotid Adenocarcinoma: A Case Report and Review of the Literature
por: Hong, Christopher S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_17cmu79akbf0n0i20cqtkb90hb